Fig. 4 | Scientific Reports

Fig. 4

From: Pharmacovigilance analysis of neurological adverse events associated with GLP-1 receptor agonists based on the FDA Adverse Event Reporting System

Fig. 4

Forest plots of signal detection for GLP-1 RA-related NAEs. (A) Results for 19 GLP-1 RA-related NAEs. (B) Recalculation of the RORs after grouping 19 GLP-1 RA-related NAEs in the FAERS database. Abbreviations: PT, Preferred Term; GLP-1 RAs, glucagon-like peptide-1 receptor agonists; NAEs, neurological adverse events; ROR, reporting odds ratio; CI, confidence interval; PRR, proportional reporting ratio; χ2, chi-squared; EBGM, empirical Bayesian geometric mean; EBGM05, the lower limit of 95% CI of EBGM; IC, information component; IC025, the lower limit of 95% CI of the IC. Note: Bold text indicates statistically significant signals per algorithm criteria.

Back to article page